AI-generated summary
The authors randomly assigned 80 pediatric patients with acute lymphoblastic leukemia receiving high-dose methotrexate to low-level laser therapy or LED therapy for oral mucositis. They report similar incidence of mucositis in the two groups (10% and 12.5%), with no significant difference in time to resolution or pain scores.
- Participants
- 80
- Who or what was studied
- Pediatric patients with acute lymphoblastic leukemia receiving high-dose methotrexate chemotherapy
- Limits stated in the abstract
- The abstract does not report the specific wavelengths used and does not describe a control group without light therapy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Oral mucositis, Low-level laser therapy, Light-emitting diode, Photobiomodulation, Laser, Visual analogue scale. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.